查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1886293

呼吸系統診斷市場－全球產業規模、佔有率、趨勢、機會和預測，按類型、檢測類型、疾病適應症、最終用途、地區和競爭格局分類，2020-2030年預測

Respiratory Diagnostics Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Test Type, By Disease Indication, By End-Use, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球呼吸系統診斷市場規模為60.2億美元，預計2030年將以7.10%的複合年成長率成長至90.9億美元。全球呼吸系統診斷市場涵蓋了用於識別、監測和管理呼吸系統疾病（包括氣喘、慢性阻塞性肺病和各種感染）的各種醫療檢測、設備、分析方法和服務。該市場的成長主要受以下因素驅動：全球呼吸系統疾病盛行率不斷上升、老年人口不斷成長且更容易患上此類疾病，以及不斷提高診斷精度和效率的技術進步。

市場概覽
預測期 2026-2030
市場規模：2024年 60.2億美元
市場規模：2030年 90.9億美元
複合年成長率：2025-2030年 7.10%
成長最快的細分市場 檢測和試劑
最大的市場 北美洲

主要市場促進因素

呼吸系統疾病日益普遍，是全球呼吸系統診斷市場的主要驅動力，直接刺激了對綜合診斷解決方案的需求。氣喘、慢性阻塞性肺病和各種感染等疾病持續對全球公共衛生構成重大挑戰，因此需要及時且準確地進行檢測，以有效管理患者。

主要市場挑戰

先進診斷設備所需的大量資本投入直接阻礙了全球呼吸系統診斷市場的成長。醫療系統和醫療服務提供者，尤其是在新興經濟體，面臨著巨大的預算限制，這限制了他們購買和升級此類關鍵技術的能力。

主要市場趨勢

人工智慧和機器學習在診斷領域的應用顯著提升了疾病檢測的精準度和效率，從而大大重塑了全球呼吸系統診斷市場。這些先進的計算方法能夠快速分析複雜資料，比傳統方法更早地識別出提示呼吸系統疾病的細微模式。

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球呼吸系統診斷市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按類型（儀器和設備、檢測和試劑、服務和軟體）
    • 按測試類型（機械測試、OSA診斷測試、影像測試、傳統診斷測試、分子診斷測試）
    • 依疾病適應症分類（結核病、氣喘、肺癌、慢性阻塞性肺病、其他）
    • 依最終用途（醫院和診所、診斷實驗室、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美呼吸系統診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲呼吸系統診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區呼吸道診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲呼吸系統診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲呼吸系統診斷市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章：全球呼吸系統診斷市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Koninklijke Philips NV
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories Inc.
  • Dragerwerk AG & Co. KGaA
  • Siemens Healthineers AG
  • PerkinElmer Inc.
  • India Medtronic Private Limited
  • Bio-Rad Laboratories, Inc.
  • GE HealthCare Technologies Inc.

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 23927

The Global Respiratory Diagnostics Market, valued at USD 6.02 Billion in 2024, is projected to experience a CAGR of 7.10% to reach USD 9.09 Billion by 2030. The global respiratory diagnostics market encompasses a diverse range of medical tests, devices, assays, and services utilized for the identification, monitoring, and management of conditions affecting the respiratory system, including asthma, chronic obstructive pulmonary disease, and various infections. This market's expansion is primarily driven by the escalating worldwide prevalence of respiratory diseases, the growing elderly population exhibiting higher susceptibility to such conditions, and continuous technological advancements that enhance diagnostic precision and efficiency.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.02 Billion
Market Size 2030USD 9.09 Billion
CAGR 2025-20307.10%
Fastest Growing SegmentAssays & Reagents
Largest MarketNorth America

Key Market Drivers

The increasing prevalence of respiratory diseases represents a fundamental driver for the global respiratory diagnostics market, directly stimulating the demand for comprehensive diagnostic solutions. Conditions such as asthma, chronic obstructive pulmonary disease, and various infections continue to pose substantial public health challenges worldwide, necessitating timely and accurate detection for effective patient management. As populations grow and environmental factors contribute to disease incidence, the imperative for robust diagnostic capabilities intensifies.

Key Market Challenges

The significant capital investment needed for advanced diagnostic equipment directly impedes the growth of the Global Respiratory Diagnostics Market. Healthcare systems and providers, particularly within emerging economies, face considerable budget constraints that limit their capacity to acquire and upgrade such essential technology. This financial barrier often delays the adoption of new, more effective diagnostic solutions, thereby restricting overall market expansion.

Key Market Trends

The integration of Artificial Intelligence and Machine Learning in diagnostics significantly reshapes the Global Respiratory Diagnostics Market by enhancing the precision and efficiency of disease detection. These advanced computational methods enable rapid analysis of complex data, identifying subtle patterns indicative of respiratory conditions earlier than traditional means.

Key Market Players

  • Koninklijke Philips N.V
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories Inc.
  • Dragerwerk AG & Co. KGaA
  • Siemens Healthineers AG
  • PerkinElmer Inc.
  • India Medtronic Private Limited
  • Bio-Rad Laboratories, Inc.
  • GE HealthCare Technologies Inc.

Report Scope:

In this report, the Global Respiratory Diagnostics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Respiratory Diagnostics Market, By Type:

  • Instruments and Devices
  • Assays & Reagents
  • Services & Software

Respiratory Diagnostics Market, By Test Type:

  • Mechanical Tests
  • OSA Diagnostic Test
  • Imaging Tests
  • Traditional Diagnostic Test
  • Molecular Diagnostic Tests

Respiratory Diagnostics Market, By Disease Indication:

  • Tuberculosis
  • Asthma
  • Lung Cancer
  • Chronic Obstructive Pulmonary Disease
  • Others

Respiratory Diagnostics Market, By End-Use:

  • Hospitals and Clinics
  • Diagnostics Laboratory
  • Others

Respiratory Diagnostics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Respiratory Diagnostics Market.

Available Customizations:

Global Respiratory Diagnostics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Respiratory Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Instruments and Devices, Assays & Reagents, Services & Software)
    • 5.2.2. By Test Type (Mechanical Tests, OSA Diagnostic Test, Imaging Tests, Traditional Diagnostic Test, Molecular Diagnostic Tests)
    • 5.2.3. By Disease Indication (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Disease, Others)
    • 5.2.4. By End-Use (Hospitals and Clinics, Diagnostics Laboratory, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Market Map

6. North America Respiratory Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Test Type
    • 6.2.3. By Disease Indication
    • 6.2.4. By End-Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Respiratory Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Test Type
        • 6.3.1.2.3. By Disease Indication
        • 6.3.1.2.4. By End-Use
    • 6.3.2. Canada Respiratory Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Test Type
        • 6.3.2.2.3. By Disease Indication
        • 6.3.2.2.4. By End-Use
    • 6.3.3. Mexico Respiratory Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Test Type
        • 6.3.3.2.3. By Disease Indication
        • 6.3.3.2.4. By End-Use

7. Europe Respiratory Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Test Type
    • 7.2.3. By Disease Indication
    • 7.2.4. By End-Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Respiratory Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Test Type
        • 7.3.1.2.3. By Disease Indication
        • 7.3.1.2.4. By End-Use
    • 7.3.2. France Respiratory Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Test Type
        • 7.3.2.2.3. By Disease Indication
        • 7.3.2.2.4. By End-Use
    • 7.3.3. United Kingdom Respiratory Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Test Type
        • 7.3.3.2.3. By Disease Indication
        • 7.3.3.2.4. By End-Use
    • 7.3.4. Italy Respiratory Diagnostics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Test Type
        • 7.3.4.2.3. By Disease Indication
        • 7.3.4.2.4. By End-Use
    • 7.3.5. Spain Respiratory Diagnostics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Test Type
        • 7.3.5.2.3. By Disease Indication
        • 7.3.5.2.4. By End-Use

8. Asia Pacific Respiratory Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Test Type
    • 8.2.3. By Disease Indication
    • 8.2.4. By End-Use
    • 8.2.5. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Respiratory Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Test Type
        • 8.3.1.2.3. By Disease Indication
        • 8.3.1.2.4. By End-Use
    • 8.3.2. India Respiratory Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Test Type
        • 8.3.2.2.3. By Disease Indication
        • 8.3.2.2.4. By End-Use
    • 8.3.3. Japan Respiratory Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Test Type
        • 8.3.3.2.3. By Disease Indication
        • 8.3.3.2.4. By End-Use
    • 8.3.4. South Korea Respiratory Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Test Type
        • 8.3.4.2.3. By Disease Indication
        • 8.3.4.2.4. By End-Use
    • 8.3.5. Australia Respiratory Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Test Type
        • 8.3.5.2.3. By Disease Indication
        • 8.3.5.2.4. By End-Use

9. Middle East & Africa Respiratory Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Test Type
    • 9.2.3. By Disease Indication
    • 9.2.4. By End-Use
    • 9.2.5. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Respiratory Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Test Type
        • 9.3.1.2.3. By Disease Indication
        • 9.3.1.2.4. By End-Use
    • 9.3.2. UAE Respiratory Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Test Type
        • 9.3.2.2.3. By Disease Indication
        • 9.3.2.2.4. By End-Use
    • 9.3.3. South Africa Respiratory Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Test Type
        • 9.3.3.2.3. By Disease Indication
        • 9.3.3.2.4. By End-Use

10. South America Respiratory Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Test Type
    • 10.2.3. By Disease Indication
    • 10.2.4. By End-Use
    • 10.2.5. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Respiratory Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Test Type
        • 10.3.1.2.3. By Disease Indication
        • 10.3.1.2.4. By End-Use
    • 10.3.2. Colombia Respiratory Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Test Type
        • 10.3.2.2.3. By Disease Indication
        • 10.3.2.2.4. By End-Use
    • 10.3.3. Argentina Respiratory Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Test Type
        • 10.3.3.2.3. By Disease Indication
        • 10.3.3.2.4. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Respiratory Diagnostics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Koninklijke Philips N.V
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Becton, Dickinson and Company
  • 15.3. Thermo Fisher Scientific Inc.
  • 15.4. Abbott Laboratories Inc.
  • 15.5. Dragerwerk AG & Co. KGaA
  • 15.6. Siemens Healthineers AG
  • 15.7. PerkinElmer Inc.
  • 15.8. India Medtronic Private Limited
  • 15.9. Bio-Rad Laboratories, Inc.
  • 15.10. GE HealthCare Technologies Inc.

16. Strategic Recommendations

17. About Us & Disclaimer